The FDA on December 23, 2016 approved the drug Spinraza for the treatment of spinal muscular atrophy (SMA). Dr. Tom Crawford, Director of the MDA Care Center at Johns Hopkins Hospital in Baltimore, Maryland, talks about the significance of the approval. For more information, go to mda.org.
Video from: https://www.youtube.com/watch?v=B0ayLo27Ros
